TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials.

Xinan Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.